Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
SYRE holding history
Spyre Therapeutics, Inc. in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRE overviewAll 13F holders of SYREFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −696,480−100.0% | Sold out | Holders |
| Q3 2024 | 696,480 | $20.5M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2024 | 696,480 | $16.4M | 0.9% | +446,480+178.6% | Added | Holders |
| Q1 2024 | 250,000 | $9.48M | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2023 | 250,000 | $5.38M | 0.3% | +250,000 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −550,000−100.0% | Sold out | Holders |
| Q2 2021 | 550,000 | $3.83M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 550,000 | $4.36M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.